How much funding has Nebula Genomics raised?

Nebula Genomics has raised $4.3M in total funding, most recently a Seed round.

Who are Nebula Genomics's investors?

Nebula Genomics's investors include Khosla Ventures, ARCH Venture Partners, F-Prime Capital, GreatPoint Ventures.

Where is Nebula Genomics headquartered?

Nebula Genomics is headquartered in Massachusetts, United States.

What industry is Nebula Genomics in?

Nebula Genomics operates in Biotech.

How many employees does Nebula Genomics have?

Nebula Genomics has 11-50 employees.

Nebula Genomics

Discover what your DNA says about your health and ancestry.

United States · $4.3M raised

Biotech

Headquarters: Massachusetts
Employees: 11–50
Business Model: B2C
Website: nebula.org

Total Funding: $4.3M
Last Round: $4.3M SeedAug 2018
Rounds: 1

About

Nebula Genomics offers 30x whole genome sequencing that analyzes 100% of a customer's DNA, providing health and ancestry insights while guaranteeing genomic data privacy. Founded in 2018 by Harvard geneticist George Church, the company was acquired by ProPhase Labs in 2021 for approximately $14.6 million. It serves both individual consumers and academic research institutions.

Summary

Nebula Genomics is a Biotech company based in United States. It has raised $4.3M in total across 1 round, most recently a $4.3M Seed round in Aug 2018. Investors include Khosla Ventures, ARCH Venture Partners and F-Prime Capital.